A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma
Figure 3.Evaluation of the independent prognostic value of the prognostic signature in the discovery cohort. (A) Univariate and (B) multivariate Cox regression analyses of the signature and clinical factors.